Protara Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Protara Therapeutics

07/08/2023 14:31

* Protara Therapeutics Inc  TARA.OQ  reported a quarterly
adjusted
loss of 100 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 87 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Protara Therapeutics Inc's reported EPS for the quarter
was a
loss of $1.00​.
    * The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Protara Therapeutics Inc shares had risen by 1.3% this
quarter and lost 9.7% so far this year.
    * The company reported a quarterly loss of $11.29 million.
    * Wall Street's median 12-month price target for Protara
Therapeutics Inc is $30.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 01:30 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.87          -1.00          Missed
 Mar. 31 2023      -0.88          -0.80          Beat
 Dec. 31 2022      -0.75          -1.55          Missed
 Sep. 30 2022      -0.76          -0.68          Beat